chronic hepatitis C
Twenty-three patients with chronic hepatitis C were treated with interferon alpha 2b plus RBV with (NYT group) or without (control group) NYT by a randomized selection.
Twenty-three patients with <span class="disease" id="15996025-5-27-46">chronic hepatitis C</span> were treated with <span class="gene" id="15996025-5-65-84">interferon alpha 2b</span> plus RBV with (NYT group) or without (control group) NYT by a randomized selection.